苏格兰西部2014-2020年喉癌:867例患者队列的趋势与生存分析
该回顾性队列研究纳入苏格兰西部2014-2020年867例喉鳞状细胞癌患者,分析人口学、分期、体能状态、治疗及社会经济剥夺情况。结果显示56%为晚期病变、70.7%居住于最贫困地区,5年总生存率为46%,声门上癌生存(36%)低于声门癌(64%),生存预测因素包括年龄、亚部位、体能状态、饮酒、治疗方式和剥夺程度。
要点
- 867例喉鳞癌患者中56%为晚期病变,70.7%居住于最贫困地区。
- 5年总生存率为46%,中位总生存52个月。
- 声门癌5年生存率64%,高于声门上癌的36%。
核心结论
- 苏格兰西部喉鳞状细胞癌的生存率低于其他欧洲国家,受晚期就诊、社会经济剥夺和衰弱影响。
- 解决这些因素对改善预后至关重要。
研究设计与样本
- 回顾性队列研究,纳入苏格兰西部2014-2020年867例喉鳞状细胞癌患者。
- 采用卡方检验比较亚组差异,Kaplan-Meier曲线、对数秩检验和Cox比例风险模型进行生存分析。
- 证据等级为3级。
主要发现
- 队列男女比例为3.2:1,平均年龄65.5岁,56%表现为晚期疾病。
- 70.7%的患者居住在最贫困地区,声门上癌为最常见亚部位(51%)。
- 5年总生存率为46%,中位总生存为52个月。
- 声门癌5年总生存率为64%,声门上癌为36%。
- 生存预测因素包括年龄、亚部位、体能状态、饮酒、治疗方式和剥夺程度。
临床怎么用
- 原文结论未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laryngeal squamous cell cancer (LSCC) accounts for around one-third of head and neck cancers, with smoking and alcohol as major risk factors. Despite advances in organ preservation, survival rates have stagnated globally over recent decades. The impact of socioeconomic deprivation on LSCC outcomes in the West of Scotland remains underexplored. We hypothesized that survival outcomes in the West of Scotland are poorer than cohorts from other developed nations. AIM: To evaluate characteristics and survival outcomes for LSCC patients in the West of Scotland and identify predictors of survival. METHODS: A retrospective cohort study of 867 LSCC patients in the West of Scotland (2014-2020) analyzed demographics, tumor staging, performance status, treatments, and socioeconomic status (Scottish Index of Multiple Deprivation, SIMD). Subgroup differences were assessed using chi-squared tests. Survival analysis was performed with Kaplan-Meier curves, log-rank tests, and Cox proportional hazards modeling. RESULTS: The cohort had a male-to-female ratio of 3.2:1, with a mean age of 65.5 years, with 56% presenting with advanced disease. Most patients (70.7%) lived in the most deprived areas. Supraglottic cancers were the most common subsite (51%). Five-year overall survival (OS) was 46%, with a median OS of 52 months. Glottic cancers had better outcomes (64% OS) compared to supraglottic cancers (36%). Predictors of survival included age, subsite, performance status, alcohol use, treatment modality, and deprivation. CONCLUSION: LSCC survival in the West of Scotland is lower than in other European nations, influenced by advanced-stage presentation, deprivation, and frailty. Addressing these factors is vital to improving outcomes. LEVEL OF EVIDENCE: 3 Laryngoscope, 135:2051-2061, 2025.
引用
- Hurley R, Paterson C, Conway DI, et al. Laryngeal Cancer in the West of Scotland 2014-2020: Trends and Survival in a Cohort of 867 Patients. Laryngoscope. 2025. PMID: 39757891. doi:10.1002/lary.31992
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。